{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:20:32Z","timestamp":1793402432105,"version":"4.5.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T00:00:00Z","timestamp":1636156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T00:00:00Z","timestamp":1636156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>People who use drugs (PWUD) often have complex health and social support needs related to substance use, yet face numerous barriers to service access, resulting in unmet treatment needs and a corresponding gap in treatment. While initiatives to scale up substance use services for PWUD in Canada - and Ontario - have been undertaken, these have excluded PWUD\u2019 perspectives, and their needs have largely been defined by other actors. As end-users of services, PWUD\u2019 perspectives are vital to understanding what services are required, and whether existent services are adequate, appropriate and effective. Thus, the present study aimed to elicit in-depth knowledge from PWUD with lived experience of accessing services to better understand their unmet treatment and service needs, towards closing the service and treatment gap in Ontario.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This qualitative study included one-on-one interviews conducted with a cohort of <jats:italic>n<\/jats:italic>\u00a0=\u200945 adult PWUD with substance use and treatment experience in Ontario, Canada. Participants were recruited from substance use services based on ConnexOntario\u2019s directory of all provincial addiction services, as well as by word-of-mouth. Questions focused on participants\u2019 experiences and perspectives on substance use services towards understanding their service needs. Data underwent an inductive thematic analysis based on key themes that emerged.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Participants commonly engaged in polysubstance use, and identified a number of unmet substance use service needs including complex factors within the current service system that influenced access to available programs. Specifically, participants suggested the need to address stigmatization and system fragmentation, increase service provision and capacity, and scale up specific services and related supports such as harm reduction, counseling, treatment, and housing.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study identified PWUD\u2019 needs in relation to substance use service provision in Ontario, Canada, and highlighted important areas for policy change and program planning and implementation. Concrete recommendations include the development of a government-funded, low-barrier, comprehensive and integrated service delivery and referral models that include PWUD as collaborators and program facilitators to ensure that services are as accessible, effective, and cohesive as possible. Results from this study can be used to enhance provincial substance use treatment and service provision.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-021-12104-w","type":"journal-article","created":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T11:02:22Z","timestamp":1636196542000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["A qualitative examination of substance use service needs among people who use drugs (PWUD) with treatment and service experience in Ontario, Canada"],"prefix":"10.1186","volume":"21","author":[{"given":"Cayley","family":"Russell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farihah","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frishta","family":"Nafeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"LeBlanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Imtiaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Elton-Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Rehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,6]]},"reference":[{"issue":"12","key":"12104_CR1","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S2215-0366(18)30337-7","volume":"5","author":"L Degenhardt","year":"2018","unstructured":"Degenhardt L, Charlson F, Ferrari A, Santomauro D, Erskine H, Mantilla-Herrara A, et al. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet Psychiatry. 2018;5(12):987\u20131012. https:\/\/doi.org\/10.1016\/S2215-0366(18)30337-7.","journal-title":"Lancet Psychiatry"},{"issue":"9810","key":"12104_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0140-6736(11)61138-0","volume":"379","author":"L Degenhardt","year":"2012","unstructured":"Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet. 2012;379(9810):55\u201370. https:\/\/doi.org\/10.1016\/S0140-6736(11)61138-0.","journal-title":"Lancet"},{"key":"12104_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.drugalcdep.2016.11.029","volume":"171","author":"S Larney","year":"2017","unstructured":"Larney S, Peacock A, Mathers BM, Hickman M, Degenhardt L. A systematic review of injecting-related injury and disease among people who inject drugs. Drug Alcohol Depend. 2017;171:39\u201349. https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.11.029.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"12104_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.comppsych.2008.07.009","volume":"50","author":"MJ Smith","year":"2009","unstructured":"Smith MJ, Thirthalli J, Abdallah AB, Murray RM, Cottler LB. Prevalence of psychotic symptoms in substance users: a comparison across substances. Compr Psychiatry. 2009;50(3):245\u201350. https:\/\/doi.org\/10.1016\/j.comppsych.2008.07.009.","journal-title":"Compr Psychiatry"},{"key":"12104_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.drugalcdep.2018.12.030","volume":"197","author":"CM Jones","year":"2019","unstructured":"Jones CM, McCance-Katz EF. Co-occurring substance use and mental disorders among adults with opioid use disorder. Drug Alcohol Depend. 2019;197:78\u201382. https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.12.030.","journal-title":"Drug Alcohol Depend"},{"key":"12104_CR6","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.drugalcdep.2018.08.013","volume":"192","author":"L-T Wu","year":"2018","unstructured":"Wu L-T, Zhu H, Ghitza UE. Multicomorbidity of chronic diseases and substance use disorders and their association with hospitalization: results from electronic health records data. Drug Alcohol Depend. 2018;192:316\u201323. https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.08.013.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"12104_CR7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2471\/BLT.12.108282","volume":"91","author":"BM Mathers","year":"2013","unstructured":"Mathers BM, Degenhardt L, Bucello C, Lemon J, Wiessing L, Hickman M. Mortality among people who inject drugs: a systematic review and meta-analysis. Bull World Health Organ. 2013;91(2):102\u201323. https:\/\/doi.org\/10.2471\/BLT.12.108282.","journal-title":"Bull World Health Organ"},{"issue":"1","key":"12104_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12954-019-0285-7","volume":"16","author":"SC Carusone","year":"2019","unstructured":"Carusone SC, Guta A, Robinson S, Tan DH, Cooper C, O\u2019Leary B, et al. Strike C: \u201cmaybe if I stop the drugs, then maybe they\u2019d care?\u201d\u2014hospital care experiences of people who use drugs. Harm Reduct J. 2019;16(1):16. https:\/\/doi.org\/10.1186\/s12954-019-0285-7.","journal-title":"Harm Reduct J"},{"key":"12104_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.drugpo.2015.11.003","volume":"28","author":"V Hope","year":"2016","unstructured":"Hope V, Parry J, Ncube F, Hickman M. Not in the vein:\u2018missed hits\u2019, subcutaneous and intramuscular injections and associated harms among people who inject psychoactive drugs in Bristol, United Kingdom. Int J Drug Policy. 2016;28:83\u201390. https:\/\/doi.org\/10.1016\/j.drugpo.2015.11.003.","journal-title":"Int J Drug Policy"},{"issue":"4","key":"12104_CR10","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/add.13214","volume":"111","author":"R McNeil","year":"2016","unstructured":"McNeil R, Kerr T, Pauly B, Wood E, Small W. Advancing patient-centered care for structurally vulnerable drug-using populations: a qualitative study of the perspectives of people who use drugs regarding the potential integration of harm reduction interventions into hospitals. Addiction. 2016;111(4):685\u201394. https:\/\/doi.org\/10.1111\/add.13214.","journal-title":"Addiction"},{"issue":"4","key":"12104_CR11","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1007\/s10900-014-9988-6","volume":"40","author":"SC Kalichman","year":"2015","unstructured":"Kalichman SC, Hernandez D, Kegler C, Cherry C, Kalichman MO, Grebler T. Dimensions of poverty and health outcomes among people living with HIV infection: limited resources and competing needs. J Community Health. 2015;40(4):702\u20138. https:\/\/doi.org\/10.1007\/s10900-014-9988-6.","journal-title":"J Community Health"},{"key":"12104_CR12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.healthplace.2015.02.008","volume":"33","author":"K Jongbloed","year":"2015","unstructured":"Jongbloed K, Thomas V, Pearce ME, Christian KW, Zhang H, Oviedo-Joekes E, et al. The cedar project: residential transience and HIV vulnerability among young Aboriginal people who use drugs. Health & Place. 2015;33:125\u201331. https:\/\/doi.org\/10.1016\/j.healthplace.2015.02.008.","journal-title":"Health & Place"},{"issue":"10","key":"12104_CR13","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1377\/hlthaff.2017.0584","volume":"36","author":"B Han","year":"2017","unstructured":"Han B, Compton WM, Blanco C, Colpe LJ. Prevalence, treatment, and unmet treatment needs of US adults with mental health and substance use disorders. Health Aff. 2017;36(10):1739\u201347. https:\/\/doi.org\/10.1377\/hlthaff.2017.0584.","journal-title":"Health Aff"},{"issue":"5","key":"12104_CR14","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/HRP.0000000000000271","volume":"28","author":"HS Connery","year":"2020","unstructured":"Connery HS, McHugh RK, Reilly M, Shin S, Greenfield SF. Substance use disorders in global mental health delivery: epidemiology, treatment gap, and implementation of evidence-based treatments. Harvard Review of Psychiatry. 2020;28(5):316\u201327. https:\/\/doi.org\/10.1097\/HRP.0000000000000271.","journal-title":"Harvard Review of Psychiatry"},{"issue":"11","key":"12104_CR15","first-page":"858","volume":"82","author":"R Kohn","year":"2004","unstructured":"Kohn R, Saxena S, Levav I, Saraceno B. The treatment gap in mental health care. Bull World Health Organ. 2004;82(11):858\u201366.","journal-title":"Bull World Health Organ"},{"issue":"1","key":"12104_CR16","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1177\/0887403403255315","volume":"15","author":"EL Jensen","year":"2004","unstructured":"Jensen EL, Gerber J, Mosher C. Social consequences of the war on drugs: the legacy of failed policy. Crim Justice Policy Rev. 2004;15(1):100\u201321. https:\/\/doi.org\/10.1177\/0887403403255315.","journal-title":"Crim Justice Policy Rev"},{"issue":"10026","key":"12104_CR17","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/S0140-6736(16)00619-X","volume":"387","author":"J Csete","year":"2016","unstructured":"Csete J, Kamarulzaman A, Kazatchkine M, Altice F, Balicki M, Buxton J, et al. Public health and international drug policy. Lancet. 2016;387(10026):1427\u201380. https:\/\/doi.org\/10.1016\/S0140-6736(16)00619-X.","journal-title":"Lancet"},{"issue":"9","key":"12104_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-035148","volume":"10","author":"AI Scheim","year":"2020","unstructured":"Scheim AI, Maghsoudi N, Marshall Z, Churchill S, Ziegler C, Werb D. Impact evaluations of drug decriminalisation and legal regulation on drug use, health and social harms: a systematic review. BMJ Open. 2020;10(9):e035148. https:\/\/doi.org\/10.1136\/bmjopen-2019-035148.","journal-title":"BMJ Open"},{"issue":"2\u20133","key":"12104_CR19","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/10826080601144580","volume":"42","author":"S Magura","year":"2007","unstructured":"Magura S. Drug prohibition and the treatment system: perfect together. Subst Use Misuse. 2007;42(2\u20133):495\u2013501. https:\/\/doi.org\/10.1080\/10826080601144580.","journal-title":"Subst Use Misuse"},{"key":"12104_CR20","doi-asserted-by":"crossref","unstructured":"Mincin J. Springer. Addiction and stigmas: overcoming labels, empowering people. In: New Directions in Treatment, Education, and Outreach for Mental Health and Addiction, 2018:125\u201331.","DOI":"10.1007\/978-3-319-72778-3_9"},{"issue":"1","key":"12104_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12875-015-0353-3","volume":"16","author":"LE Ross","year":"2015","unstructured":"Ross LE, Vigod S, Wishart J, Waese M, Spence JD, Oliver J, et al. Barriers and facilitators to primary care for people with mental health and\/or substance use issues: a qualitative study. BMC Fam Pract. 2015;16(1):135. https:\/\/doi.org\/10.1186\/s12875-015-0353-3.","journal-title":"BMC Fam Pract"},{"key":"12104_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jsat.2015.09.006","volume":"61","author":"MA Priester","year":"2016","unstructured":"Priester MA, Browne T, Iachini A, Clone S, DeHart D, Seay KD. Treatment access barriers and disparities among individuals with co-occurring mental health and substance use disorders: an integrative literature review. J Subst Abus Treat. 2016;61:47\u201359. https:\/\/doi.org\/10.1016\/j.jsat.2015.09.006.","journal-title":"J Subst Abus Treat"},{"issue":"6","key":"12104_CR23","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1080\/10826084.2019.1710207","volume":"55","author":"L Miller-Lloyd","year":"2020","unstructured":"Miller-Lloyd L, Landry J, Macmadu A, Allard I, Waxman M. Barriers to healthcare for people who inject drugs: a survey at a syringe exchange program. Subst Use Misuse. 2020;55(6):896\u20139. https:\/\/doi.org\/10.1080\/10826084.2019.1710207.","journal-title":"Subst Use Misuse"},{"issue":"1\u20132","key":"12104_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.drugalcdep.2013.02.018","volume":"131","author":"LC Van Boekel","year":"2013","unstructured":"Van Boekel LC, Brouwers EP, Van Weeghel J, Garretsen HF. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013;131(1\u20132):23\u201335. https:\/\/doi.org\/10.1016\/j.drugalcdep.2013.02.018.","journal-title":"Drug Alcohol Depend"},{"key":"12104_CR25","doi-asserted-by":"publisher","first-page":"102991","DOI":"10.1016\/j.drugpo.2020.102991","volume":"88","author":"M-M Urbanik","year":"2021","unstructured":"Urbanik M-M, Greene C. Operational and contextual barriers to accessing supervised consumption services in two Canadian cities. Int J Drug Policy. 2021;88:102991. https:\/\/doi.org\/10.1016\/j.drugpo.2020.102991.","journal-title":"Int J Drug Policy"},{"issue":"8","key":"12104_CR26","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1177\/0706743717714467","volume":"62","author":"K Urbanoski","year":"2017","unstructured":"Urbanoski K, Inglis D, Veldhuizen S. Service use and unmet needs for substance use and mental disorders in Canada. Can J Psychiatr. 2017;62(8):551\u20139. https:\/\/doi.org\/10.1177\/0706743717714467.","journal-title":"Can J Psychiatr"},{"issue":"3 Suppl","key":"12104_CR27","doi-asserted-by":"publisher","first-page":"ES191","DOI":"10.36076\/ppj.2012\/15\/ES191","volume":"15","author":"B Fischer","year":"2012","unstructured":"Fischer B, Argento E. Prescription opioid related misuse, harms, diversion and interventions in Canada: a review. Pain Physician. 2012;15(3 Suppl):ES191\u2013203. https:\/\/doi.org\/10.36076\/ppj.2012\/15\/ES191.","journal-title":"Pain Physician"},{"issue":"3","key":"12104_CR28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1176\/ps.2008.59.3.283","volume":"59","author":"KA Urbanoski","year":"2008","unstructured":"Urbanoski KA, Cairney J, Bassani DG, Rush BR. Perceived unmet need for mental health care for Canadians with co-occurring mental and substance use disorders. Psychiatr Serv. 2008;59(3):283\u20139. https:\/\/doi.org\/10.1176\/ps.2008.59.3.283.","journal-title":"Psychiatr Serv"},{"issue":"6","key":"12104_CR29","doi-asserted-by":"publisher","first-page":"224","DOI":"10.24095\/hpcdp.38.6.02","volume":"38","author":"L Belzak","year":"2018","unstructured":"Belzak L, Halverson J. The opioid crisis in Canada: a national perspective. Health Promot Chronic Dis Prev Can. 2018;38(6):224\u201333. https:\/\/doi.org\/10.24095\/hpcdp.38.6.02.","journal-title":"Health Promot Chronic Dis Prev Can"},{"key":"12104_CR30","unstructured":"Government of Canada: Opioid- and Stimulant-Related Harms in Canada. 2020. Ottawa, Ontario: Government of Canada. Retrieved from:https:\/\/health-infobase.canada.ca\/substance-related-harms\/opioids\/maps?index=1"},{"key":"12104_CR31","unstructured":"Government of Canada: Federal Action on Opioids to Date. 2021. Ottawa, Ontario: Government of Canada. Retrieved from:https:\/\/www.canada.ca\/en\/health-canada\/services\/opioids\/federal-actions\/overview.html"},{"key":"12104_CR32","unstructured":"Canadian Centre on Substance Use and Addiction (CCSA): National Treatment Indicators Report: 2016\u20132018 Data. 2021. Ottawa, Ontario: Canadian Centre on Substance Use and Addiction (CCSA). Retrieved from:https:\/\/www.ccsa.ca\/sites\/default\/files\/2021-01\/CCSA-National-Treatment-Indicators-2016-2018-Data-Report-2021-en.pdf"},{"key":"12104_CR33","unstructured":"Network CHAL: Gendering the Scene: Women, Gender-Diverse People, and Harm Reduction in Canada. 2020. Toronto, Ontario: Canadian HIV\/AIDS Legal Network Retrieved from:http:\/\/www.hivlegalnetwork.ca\/site\/gendering-the-scene-women-gender-diverse-people-and-harm-reduction-in-canada-full-report\/?lang=en"},{"key":"12104_CR34","unstructured":"Government of Canada: Federal Action on Opioids - Overview. 2020. Government of Canada. Retrieved from:https:\/\/www.canada.ca\/en\/health-canada\/services\/substance-use\/problematic-prescription-drug-use\/opioids\/federal-actions\/overview.html"},{"key":"12104_CR35","unstructured":"Public Health Agency of Canada (PHAC): A Primer to reduce Substance Use Stigma in the Canadian Health System. 2020. Ottawa, Ontario: Public Health Agency of Canada (PHAC). Retrieved from:https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/documents\/services\/publications\/healthy-living\/primer-reduce-substance-use-stigma-health-system\/stigma-primer-eng.pdf"},{"key":"12104_CR36","unstructured":"Government of Canada: Emergency Treatment Fund. 2019. Government of Canada. Retrieved from:https:\/\/www.canada.ca\/en\/health-canada\/services\/substance-use\/problematic-prescription-drug-use\/opioids\/responding-canada-opioid-crisis\/emergency-treatment-fund.html"},{"key":"12104_CR37","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.drugpo.2019.02.005","volume":"71","author":"C Strike","year":"2019","unstructured":"Strike C, Watson TM. Losing the uphill battle? Emergent harm reduction interventions and barriers during the opioid overdose crisis in Canada. Int J Drug Policy. 2019;71:178\u201382. https:\/\/doi.org\/10.1016\/j.drugpo.2019.02.005.","journal-title":"Int J Drug Policy"},{"key":"12104_CR38","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.drugpo.2018.12.014","volume":"71","author":"E Hyshka","year":"2019","unstructured":"Hyshka E, Anderson-Baron J, Pugh A, Belle-Isle L, Hathaway A, Pauly B, et al. Principles, practice, and policy vacuums: policy actor views on provincial\/territorial harm reduction policy in Canada. Int J Drug Policy. 2019;71:142\u20139. https:\/\/doi.org\/10.1016\/j.drugpo.2018.12.014.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"12104_CR39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13011-017-0130-5","volume":"12","author":"KA Morin","year":"2017","unstructured":"Morin KA, Eibl JK, Franklyn AM, Marsh DC. The opioid crisis: past, present and future policy climate in Ontario. Canada Subst Abuse Treat Prev Policy. 2017;12(1):45. https:\/\/doi.org\/10.1186\/s13011-017-0130-5.","journal-title":"Canada Subst Abuse Treat Prev Policy"},{"issue":"2","key":"12104_CR40","doi-asserted-by":"publisher","first-page":"8(2)","DOI":"10.13162\/hro-ors.v8i2.4114","volume":"8","author":"C Manson-Singer","year":"2020","unstructured":"Manson-Singer C, Allin S. Understanding the Policy Context and Conditions Necessary for the Establishment of Supervised Consumption Sites in Canada: A Comparative Analysis of Alberta and Manitoba. Health Reform Observer\u2013Observatoire des R\u00e9formes de Sant\u00e9. 2020;8(2):8(2). https:\/\/doi.org\/10.13162\/hro-ors.v8i2.4114.","journal-title":"Health Reform Observer\u2013Observatoire des R\u00e9formes de Sant\u00e9"},{"key":"12104_CR41","unstructured":"Pirie T, Wallingford SC, Di Gioacchino LA, McQuaid RJ: National Treatment Indicators Report: 2013\u20132014. 2016. Ottawa, ON: Canadian Centre on Substance Abuse (CCSA). Retrieved from:http:\/\/www.ccsa.ca\/Resource%20Library\/CCSA-National-Treatment-Indicators-Report-2016-en.pdf"},{"key":"12104_CR42","unstructured":"Addictions and Mental Health Ontario (AMHO): Residential Treatment of Adult Substance Use Disorders. 2019. Toronto, Ontario: Addictions and Mental Health Ontario (AMHO). Retrieved from:https:\/\/amho.ca\/wp-content\/uploads\/Residential-Treatment-of-Adult-Substance-Use-Disorders-Position-Paper.pdf"},{"key":"12104_CR43","unstructured":"Canadian Centre on Substance Use and Addiction (CCSA): Finding Quality Addiction Care in Canada. 2017. Ottawa, Ontario: Canadian Centre on Substance Use and Addiction (CCSA). Retrieved from:https:\/\/ccsa.ca\/sites\/default\/files\/2019-04\/CCSA-Addiction-Care-in-Canada-Treatment-Guide-2017-en.pdf"},{"key":"12104_CR44","unstructured":"Addiction Rehab Toronto. How Much Does a Drug Addiction Rehab Cost in Canada? 2021. Retrieved from:[https:\/\/addictionrehabtoronto.ca\/cost-drug-addiction-rehab-canada\/]."},{"key":"12104_CR45","doi-asserted-by":"publisher","unstructured":"Russell C, Imtiaz S, Ali F, Elton-Marshall T, Rehm J. \u2018Small communities, large oversight\u2019: the impact of recent legislative changes concerning supervised consumption services on small communities in Ontario. Canada. Int J Drug Policy. 2020;82:102822. https:\/\/doi.org\/10.1016\/j.drugpo.2020.102822.","DOI":"10.1016\/j.drugpo.2020.102822"},{"key":"12104_CR46","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.drugpo.2019.09.006","volume":"74","author":"BR Ziegler","year":"2019","unstructured":"Ziegler BR, Wray AJD, Luginaah I. The ever-changing narrative: supervised injection site policy making in Ontario, Canada. Int J Drug Policy. 2019;74:98\u2013111. https:\/\/doi.org\/10.1016\/j.drugpo.2019.09.006.","journal-title":"Int J Drug Policy"},{"issue":"14","key":"12104_CR47","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1097\/QAD.0b013e32823f9066","volume":"21","author":"RS Garfein","year":"2007","unstructured":"Garfein RS, Golub ET, Greenberg AE, Hagan H, Hanson DL, Hudson SM, et al. A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users. AIDS. 2007;21(14):1923\u201332. https:\/\/doi.org\/10.1097\/QAD.0b013e32823f9066.","journal-title":"AIDS"},{"issue":"2","key":"12104_CR48","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1108\/09526860510588133","volume":"18","author":"V Minogue","year":"2005","unstructured":"Minogue V, Boness J, Brown A, Girdlestone J. The impact of service user involvement in research. International Journal of Health Care Quality Assurance. 2005;18(2):103\u201312. https:\/\/doi.org\/10.1108\/09526860510588133.","journal-title":"International Journal of Health Care Quality Assurance"},{"issue":"7","key":"12104_CR49","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1176\/appi.ps.201400047","volume":"65","author":"S Reif","year":"2014","unstructured":"Reif S, Braude L, Lyman DR, Dougherty RH, Daniels AS, Ghose SS, et al. Peer recovery support for individuals with substance use disorders: assessing the evidence. Psychiatr Serv. 2014;65(7):853\u201361. https:\/\/doi.org\/10.1176\/appi.ps.201400047.","journal-title":"Psychiatr Serv"},{"issue":"1","key":"12104_CR50","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1747-597X-7-47","volume":"7","author":"L Ti","year":"2012","unstructured":"Ti L, Tzemis D, Buxton JA. Engaging people who use drugs in policy and program development: a review of the literature. Subst Abuse Treat Prev Policy. 2012;7(1):47. https:\/\/doi.org\/10.1186\/1747-597X-7-47.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"12104_CR51","unstructured":"Greer AM, Amlani AA, Buxton JA, Team P: Peer Engagement Best Practices: A Guide for Health Authorities and other providers. 2017. Vancouver, B.C.: B.C. Centre for Disease Control. Retrieved from:http:\/\/www.bccdc.ca\/resource-gallery\/Documents\/PEEP%20Best%20Practice%20Guidelines.pdf"},{"key":"12104_CR52","unstructured":"Burklow KA, Mills LC. Giving voice to underserved and culturally diverse groups using community-based participatory research. The Open Medical Education Journal. 2009;2(1)."},{"issue":"2","key":"12104_CR53","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3109\/09687637.2013.838211","volume":"21","author":"K Lancaster","year":"2014","unstructured":"Lancaster K, Sutherland R, Ritter A. Examining the opinions of people who use drugs towards drug policy in Australia. Drugs: Education, Prevention and Policy. 2014;21(2):93\u2013101. https:\/\/doi.org\/10.3109\/09687637.2013.838211.","journal-title":"Drugs: Education, Prevention and Policy"},{"key":"12104_CR54","unstructured":"Satcher D: Methods in community-based participatory research for health: John Wiley & Sons; 2005."},{"issue":"1","key":"12104_CR55","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12910-016-0108-2","volume":"17","author":"R Souleymanov","year":"2016","unstructured":"Souleymanov R, Kuzmanovi\u0107 D, Marshall Z, Scheim AI, Mikiki M, Worthington C, et al. The ethics of community-based research with people who use drugs: results of a scoping review. BMC Medical Ethics. 2016;17(1):25. https:\/\/doi.org\/10.1186\/s12910-016-0108-2.","journal-title":"BMC Medical Ethics"},{"key":"12104_CR56","unstructured":"Watts M, Newell S, Putyra M: Ontario Taking Next Steps to Integrate Health Care System. 2019. Toronto, ON: Osler. Retrieved from:https:\/\/www.osler.com\/en\/resources\/regulations\/2019\/ontario-taking-next-steps-to-integrate-health-care-system"},{"key":"12104_CR57","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.drugpo.2018.04.004","volume":"57","author":"CE Paquette","year":"2018","unstructured":"Paquette CE, Syvertsen JL, Pollini RA. Stigma at every turn: health services experiences among people who inject drugs. Int J Drug Policy. 2018;57:104\u201310. https:\/\/doi.org\/10.1016\/j.drugpo.2018.04.004.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"12104_CR58","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0192513X15581659","volume":"39","author":"KL Stringer","year":"2018","unstructured":"Stringer KL, Baker EH. Stigma as a barrier to substance abuse treatment among those with unmet need: an analysis of parenthood and marital status. J Fam Issues. 2018;39(1):3\u201327. https:\/\/doi.org\/10.1177\/0192513X15581659.","journal-title":"J Fam Issues"},{"issue":"1","key":"12104_CR59","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11606-016-3799-7","volume":"32","author":"SE Wakeman","year":"2017","unstructured":"Wakeman SE, Rich JD. Barriers to post-acute care for patients on opioid agonist therapy; an example of systematic stigmatization of addiction. In: Springer. 2017;32(1):17\u20139. https:\/\/doi.org\/10.1007\/s11606-016-3799-7.","journal-title":"In: Springer"},{"issue":"2","key":"12104_CR60","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3109\/09687637.2012.743506","volume":"20","author":"C Lloyd","year":"2013","unstructured":"Lloyd C. The stigmatization of problem drug users: a narrative literature review. Drugs: education, prevention and policy. 2013;20(2):85\u201395. https:\/\/doi.org\/10.3109\/09687637.2012.743506.","journal-title":"Drugs: education, prevention and policy"},{"key":"12104_CR61","doi-asserted-by":"publisher","unstructured":"Luoma JB. Substance use stigma as a barrier to treatment and recovery. In: Addiction Medicine edn: Springer. 2010:1195\u2013215. https:\/\/doi.org\/10.1007\/978-1-4419-0338-9_59.","DOI":"10.1007\/978-1-4419-0338-9_59"},{"issue":"1","key":"12104_CR62","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1360-0443.2011.03601.x","volume":"107","author":"JD Livingston","year":"2012","unstructured":"Livingston JD, Milne T, Fang ML, Amari E. The effectiveness of interventions for reducing stigma related to substance use disorders: a systematic review. Addiction. 2012;107(1):39\u201350. https:\/\/doi.org\/10.1111\/j.1360-0443.2011.03601.x.","journal-title":"Addiction"},{"key":"12104_CR63","unstructured":"National Academies of Sciences Engineering and Medicine: Ending discrimination against people with mental and substance use disorders: The evidence for stigma change. 2016. Washington, D.C. : National Academies Press. Retrieved from:https:\/\/pubmed.ncbi.nlm.nih.gov\/27631043\/"},{"issue":"4","key":"12104_CR64","doi-asserted-by":"publisher","first-page":"392","DOI":"10.2975\/27.2004.392.401","volume":"27","author":"P Solomon","year":"2004","unstructured":"Solomon P. Peer support\/peer provided services underlying processes, benefits, and critical ingredients. Psychiatric rehabilitation journal. 2004;27(4):392\u2013401. https:\/\/doi.org\/10.2975\/27.2004.392.401.","journal-title":"Psychiatric rehabilitation journal"},{"key":"12104_CR65","volume-title":"Engaging people with lived experience for better health outcomes: collaboration with mental health and addiction service users in research, policy, and treatment","author":"R Cheng","year":"2009","unstructured":"Cheng R, Smith C. Engaging people with lived experience for better health outcomes: collaboration with mental health and addiction service users in research, policy, and treatment. Toronto: Ontario Ministry of Health and Long-Term Care; 2009."},{"key":"12104_CR66","unstructured":"Mings E, Cramp J: Best Practices in Peer Support: 2014 Final Report. 2014. Toronto, Ontario: Addictions and Mental Health Ontario. Retrieved from:https:\/\/www.eenet.ca\/sites\/default\/files\/wp-content\/uploads\/2014\/08\/Best-Practices-PeerSupport-Final-Report-2014.pdf"},{"key":"12104_CR67","unstructured":"Buxton J, Stevenson J, LaCroix K, Burmeister C: Primer: The Role of Peers for BC Overdose Action Exchange. 2016. Vancouver, B.C.: British Columbia Centre for Disease Control (BCCDC). Retrieved from:http:\/\/www.bccdc.ca\/resource-gallery\/Documents\/Educational%20Materials\/Epid\/Other\/Peer%20primer%20for%20BCOAE.pdf"},{"issue":"3","key":"12104_CR68","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1037\/sah0000148","volume":"4","author":"E Burke","year":"2019","unstructured":"Burke E, Pyle M, Machin K, Varese F, Morrison AP. The effects of peer support on empowerment, self-efficacy, and internalized stigma: a narrative synthesis and meta-analysis. Stigma and health. 2019;4(3):337\u201356. https:\/\/doi.org\/10.1037\/sah0000148.","journal-title":"Stigma and health"},{"issue":"3","key":"12104_CR69","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1108\/MHSI-03-2017-0014","volume":"21","author":"C Bellamy","year":"2017","unstructured":"Bellamy C, Schmutte T, Davidson L. An update on the growing evidence base for peer support. Ment Health Soc Incl. 2017;21(3):161\u20137. https:\/\/doi.org\/10.1108\/MHSI-03-2017-0014.","journal-title":"Ment Health Soc Incl"},{"issue":"1","key":"12104_CR70","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/1472-6963-13-188","volume":"13","author":"SG Gillard","year":"2013","unstructured":"Gillard SG, Edwards C, Gibson SL, Owen K, Wright C. Introducing peer worker roles into UK mental health service teams: a qualitative analysis of the organisational benefits and challenges. BMC Health Serv Res. 2013;13(1):188. https:\/\/doi.org\/10.1186\/1472-6963-13-188.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"12104_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-020-00453-5","volume":"18","author":"B Abele","year":"2021","unstructured":"Abele B, Bowser J, Brown L, Carette J, Crichlow F, de Kiewit A, et al. Having a voice and saving lives: a qualitative survey on employment impacts of people with lived experience of drug use working in harm reduction. Harm Reduct J. 2021;18(1):1. https:\/\/doi.org\/10.1186\/s12954-020-00453-5.","journal-title":"Harm Reduct J"},{"key":"12104_CR72","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.socscimed.2019.02.014","volume":"225","author":"MC Kennedy","year":"2019","unstructured":"Kennedy MC, Boyd J, Mayer S, Collins A, Kerr T, McNeil R. Peer worker involvement in low-threshold supervised consumption facilities in the context of an overdose epidemic in Vancouver, Canada. Soc Sci Med. 2019;225:60\u20138. https:\/\/doi.org\/10.1016\/j.socscimed.2019.02.014.","journal-title":"Soc Sci Med"},{"key":"12104_CR73","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.ijnurstu.2016.04.018","volume":"60","author":"J Vandewalle","year":"2016","unstructured":"Vandewalle J, Debyser B, Beeckman D, Vandecasteele T, Van Hecke A, Verhaeghe S. Peer workers\u2019 perceptions and experiences of barriers to implementation of peer worker roles in mental health services: a literature review. Int J Nurs Stud. 2016;60:234\u201350. https:\/\/doi.org\/10.1016\/j.ijnurstu.2016.04.018.","journal-title":"Int J Nurs Stud"},{"key":"12104_CR74","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.drugalcdep.2016.10.001","volume":"168","author":"C Cumming","year":"2016","unstructured":"Cumming C, Troeung L, Young JT, Kelty E, Preen DB. Barriers to accessing methamphetamine treatment: a systematic review and meta-analysis. Drug Alcohol Depend. 2016;168:263\u201373. https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.10.001.","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"12104_CR75","doi-asserted-by":"publisher","first-page":"339","DOI":"10.12788\/jhm.2736","volume":"12","author":"H Englander","year":"2017","unstructured":"Englander H, Weimer M, Solotaroff R, Nicolaidis C, Chan B, Velez C, et al. Planning and designing the improving addiction care team (IMPACT) for hospitalized adults with substance use disorder. J Hosp Med. 2017;12(5):339\u201342. https:\/\/doi.org\/10.12788\/jhm.2736.","journal-title":"J Hosp Med"},{"key":"12104_CR76","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.drugalcdep.2014.02.702","volume":"139","author":"M-L Brecht","year":"2014","unstructured":"Brecht M-L, Herbeck D. Time to relapse following treatment for methamphetamine use: a long-term perspective on patterns and predictors. Drug Alcohol Depend. 2014;139:18\u201325. https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.02.702.","journal-title":"Drug Alcohol Depend"},{"key":"12104_CR77","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jsat.2016.07.010","volume":"70","author":"C Timko","year":"2016","unstructured":"Timko C, Schultz NR, Britt J, Cucciare MA. Transitioning from detoxification to substance use disorder treatment: facilitators and barriers. J Subst Abus Treat. 2016;70:64\u201372. https:\/\/doi.org\/10.1016\/j.jsat.2016.07.010.","journal-title":"J Subst Abus Treat"},{"issue":"7","key":"12104_CR78","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3109\/10826084.2014.891615","volume":"49","author":"E Pullen","year":"2014","unstructured":"Pullen E, Oser C. Barriers to substance abuse treatment in rural and urban communities: counselor perspectives. Subst Use Misuse. 2014;49(7):891\u2013901. https:\/\/doi.org\/10.3109\/10826084.2014.891615.","journal-title":"Subst Use Misuse"},{"issue":"3","key":"12104_CR79","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0306-4603(94)90035-3","volume":"19","author":"SM Ross","year":"1994","unstructured":"Ross SM, Turner C. Physical proximity as a possible facilitator in post-detoxification treatment-seeking among chemically dependent veterans. Addict Behav. 1994;19(3):343\u20138. https:\/\/doi.org\/10.1016\/0306-4603(94)90035-3.","journal-title":"Addict Behav"},{"issue":"1","key":"12104_CR80","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1081\/ADA-120029870","volume":"30","author":"PW Appel","year":"2004","unstructured":"Appel PW, Ellison AA, Jansky HK, Oldak R. Barriers to enrollment in drug abuse treatment and suggestions for reducing them: opinions of drug injecting street outreach clients and other system stakeholders. The American journal of drug and alcohol abuse. 2004;30(1):129\u201353. https:\/\/doi.org\/10.1081\/ADA-120029870.","journal-title":"The American journal of drug and alcohol abuse"},{"issue":"4","key":"12104_CR81","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1080\/08897077.2014.996697","volume":"36","author":"SL Calcaterra","year":"2015","unstructured":"Calcaterra SL, Keniston A, Blum J, Crume T, Binswanger IA. The association between stimulant, opioid, and multiple drug use on behavioral health care utilization in a safety-net health system. Subst Abus. 2015;36(4):407\u201312. https:\/\/doi.org\/10.1080\/08897077.2014.996697.","journal-title":"Subst Abus"},{"key":"12104_CR82","unstructured":"Mentoring E, and Clinical Tools for Addiction: Partners in Health Integration (META:PHI): A Guide to Rapid Access Addiction Medicine (RAAM) Clinics. 2019. Toronto, Ontario: Women's College Hospital. Retrieved from:https:\/\/www.metaphi.ca\/assets\/documents\/the%20model\/GuideToRAAMClinics.pdf"},{"issue":"31","key":"12104_CR83","doi-asserted-by":"publisher","first-page":"E921","DOI":"10.1503\/cmaj.180824","volume":"190","author":"A Scheim","year":"2018","unstructured":"Scheim A, Werb D. Integrating supervised consumption into a continuum of care for people who use drugs. Can Med Assoc J. 2018;190(31):E921\u20132. https:\/\/doi.org\/10.1503\/cmaj.180824.","journal-title":"Can Med Assoc J"},{"key":"12104_CR84","doi-asserted-by":"publisher","first-page":"102245","DOI":"10.1016\/j.healthplace.2019.102245","volume":"61","author":"G Bardwell","year":"2020","unstructured":"Bardwell G, Strike C, Mitra S, Scheim A, Barnaby L, Altenberg J, et al. \u201cThat's a double-edged sword\u201d: exploring the integration of supervised consumption services within community health centres in Toronto. Canada Health & Place. 2020;61:102245. https:\/\/doi.org\/10.1016\/j.healthplace.2019.102245.","journal-title":"Canada Health & Place"},{"key":"12104_CR85","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jsat.2019.03.007","volume":"101","author":"LA Lin","year":"2019","unstructured":"Lin LA, Casteel D, Shigekawa E, Weyrich MS, Roby DH, McMenamin SB. Telemedicine-delivered treatment interventions for substance use disorders: a systematic review. J Subst Abus Treat. 2019;101:38\u201349. https:\/\/doi.org\/10.1016\/j.jsat.2019.03.007.","journal-title":"J Subst Abus Treat"},{"issue":"4","key":"12104_CR86","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1177\/0160323X20929053","volume":"51","author":"AD Bagchi","year":"2019","unstructured":"Bagchi AD. Expansion of telehealth across the rural\u2013urban continuum. State and Local Government Review. 2019;51(4):250\u20138. https:\/\/doi.org\/10.1177\/0160323X20929053.","journal-title":"State and Local Government Review"},{"issue":"1","key":"12104_CR87","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11414-012-9299-6","volume":"40","author":"S Benavides-Vaello","year":"2013","unstructured":"Benavides-Vaello S, Strode A, Sheeran BC. Using Technology in the Delivery of mental health and substance abuse treatment in rural communities: a review. The Journal of Behavioral Health Services & Research. 2013;40(1):111\u201320. https:\/\/doi.org\/10.1007\/s11414-012-9299-6.","journal-title":"The Journal of Behavioral Health Services & Research"},{"key":"12104_CR88","unstructured":"Government of Ontario: Improving Quality Mental Health and Addictions Services Across Ontario. 2019. Toronto, ON: Ministry of Health and Long Term Care Ontario Retrieved from:https:\/\/news.ontario.ca\/mohltc\/en\/2019\/05\/improving-quality-mental-health-and-addictions-services-across-ontario.html"},{"key":"12104_CR89","unstructured":"Government of Ontario: Ontario Unveils Plan to Build Mental Health and Addictions System. 2020. Toronto, ON: Ministry of Health and Long Term Care Retrieved from:https:\/\/news.ontario.ca\/mohltc\/en\/2020\/03\/ontario-unveils-plan-to-build-mental-health-and-addictions-system.html"},{"key":"12104_CR90","unstructured":"Ontario Ministry of Health and Long-Term Care. Become an Ontario Health Team 2021. Retrieved from:[https:\/\/health.gov.on.ca\/en\/pro\/programs\/connectedcare\/oht\/]."},{"key":"12104_CR91","unstructured":"Addictions and Mental Health Ontario (AMHO): Together We Can: Investing in Addiction & Mental Health Services in Ontario. 2020. Toronto, Ontario: Addictions and Mental Health Ontario (AMHO). Retrieved from:https:\/\/amho.ca\/wp-content\/uploads\/AMHO_BudgetSubmission_Feb2020_FINAL.pdf"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-12104-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-021-12104-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-12104-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T11:02:35Z","timestamp":1636196555000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-021-12104-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,6]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["12104"],"URL":"https:\/\/doi.org\/10.1186\/s12889-021-12104-w","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,6]]},"assertion":[{"value":"26 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol and all procedures were approved by the Centre for Addiction and Mental Health (CAMH) Research Ethics Board (REB# 064\/2019). Written informed consent was obtained from all subjects and all methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2021"}}